Vaxcyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.About PCVX
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.
CEOGrant E. Pickering
CEOGrant E. Pickering
Employees414
Employees414
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2013
Founded2013
Employees414
Employees414
PCVX Key Statistics
Market cap5.63B
Market cap5.63B
Price-Earnings ratio-8.75
Price-Earnings ratio-8.75
Dividend yield—
Dividend yield—
Average volume1.37M
Average volume1.37M
High today—
High today—
Low today—
Low today—
Open price$43.90
Open price$43.90
Volume2.35K
Volume2.35K
52 Week high$93.77
52 Week high$93.77
52 Week low$27.66
52 Week low$27.66
Stock Snapshot
Vaxcyte(PCVX) stock is priced at $43.15, giving the company a market capitalization of 5.63B. It carries a P/E multiple of -8.75.
On 2025-12-18, Vaxcyte(PCVX) stock opened at $43.90, reached a high of —, and a low of —.
The Vaxcyte(PCVX)'s current trading volume is 2.35K, compared to an average daily volume of 1.37M.
In the last year, Vaxcyte(PCVX) shares hit a 52-week high of $93.77 and a 52-week low of $27.66.
In the last year, Vaxcyte(PCVX) shares hit a 52-week high of $93.77 and a 52-week low of $27.66.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own PCVX. This list is generated using Robinhood data, and it’s not a recommendation.